Cambridge Investment Research Advisors’s Fidelity Enhanced Small Cap Core ETF FESM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Buy
285,212
+48,034
+20% +$2.11M 0.03% 545
2026
Q1
$9.01M Buy
237,178
+60,085
+34% +$2.36M 0.02% 655
2025
Q4
$6.69M Buy
177,093
+38,199
+28% +$1.42M 0.02% 772
2025
Q3
$5.08M Sell
138,894
-1,330
-0.9% -$45.7K 0.01% 906
2025
Q2
$4.49M Sell
140,224
-3,503
-2% -$104K 0.01% 912
2025
Q1
$4.24M Buy
143,727
+83,426
+138% +$2.67M 0.01% 891
2024
Q4
$1.95M Buy
60,301
+11,387
+23% +$381K 0.01% 1373
2024
Q3
$1.57M Buy
48,914
+32,034
+190% +$989K 0.01% 1541
2024
Q2
$491K Buy
16,880
+7,321
+77% +$211K ﹤0.01% 2314
2024
Q1
$287K Buy
9,559
+2,215
+30% +$63K ﹤0.01% 2730
2023
Q4
$207K Buy
+7,344
New +$194K ﹤0.01% 2874

Other funds holding FESM

Cambridge Investment Research Advisors's FESM Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Fidelity Enhanced Small Cap Core ETF (FESM) stake by 20% in Q2 2026, buying an estimated $2.11M and bringing the position to 285,212 shares worth $13.8M. The position accounts for 0.03% of the portfolio, ranked #545.

Cambridge Investment Research Advisors first reported a position in FESM in Q4 2023 and has held it in 11 quarters since. 256 funds tracked by Wall St. Rank hold FESM as of Q2 2026.

  • Cambridge Investment Research Advisors held 285,212 shares of Fidelity Enhanced Small Cap Core ETF worth $13.8M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 48,034 Fidelity Enhanced Small Cap Core ETF shares in Q2 2026, an estimated $2.11M.
  • Fidelity Enhanced Small Cap Core ETF made up 0.03% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #545 holding.
  • Cambridge Investment Research Advisors first reported a position in Fidelity Enhanced Small Cap Core ETF in Q4 2023 and has held it in 11 quarters since.
  • 256 funds tracked by Wall St. Rank held Fidelity Enhanced Small Cap Core ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.